Open AccessLocalization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence
Author(s) -
Nikhil Seniaray,
Ritu Verma,
Sudhir Khanna,
Ethel Shangne Belho,
A. K. Pruthi,
Harsh Mahajan
Publication year - 2020
Publication title -
indian journal of urology/indian journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.333
H-Index - 30
eISSN - 1998-3824
pISSN - 0970-1591
DOI - 10.4103/iju.iju_275_19
Subject(s) - medicine , biochemical recurrence , glutamate carboxypeptidase ii , prostate cancer , prostatectomy , positron emission tomography , prostate , prostate specific antigen , urology , nuclear medicine , positron emission tomography computed tomography , prospective cohort study , cancer , radiology
Radical prostatectomy (RP) and radical radiotherapy (RT) are well established primary curative options for localized prostate cancer. Despite technical improvements, prostate-specific antigen (PSA)-recurrence after RP and RT is a common clinical scenario. We aimed to assess the role of 68 Gallium ( 68 Ga) prostate-specific membrane antigen positron emission tomography computed tomography (PSMA PET/CT) in patients with biochemical recurrence of prostate cancer after RP or RT for the detection and localization recurrent and metastatic disease.